ARIAD Pharmaceuticals Competitors and Similar CompaniesClear all
ARIAD Pharmaceuticals's competitors and similar companies include GlycoMimetics and ViroStatics.
 ARIAD Pharmaceuticals ARIAD Pharmaceuticals is a global oncology company focused on discovering, developing and commercializing precision therapies for patients with rare cancers. |  GlycoMimetics GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers. | ||
Founding Date | Founding Date 1991 | Founding Date 2003 | Founding Date 2005 |
Type | Type Subsidiary | Type Public | Type Private |
Tags | |||
Locations | Locations Cambridge, US HQ Boston, US Chicago, US Cincinnati, US Dallas, US Minneapolis, US New York, US see more | Locations Rockville, US HQ | Locations Sassari, IT HQ Tramariglio, IT |
Employees | Employees 1381% increase | Employees 5025% increase | Employees 8 |
Financial | |||
Revenue (est.) | Revenue (est.) $118.8m (FY, 2015) | Revenue (est.) $10.8m (FY, 2025) | Revenue (est.) N/A |
Net income | Net income ($231.2m) (FY, 2015) | Net income ($153.9m) (FY, 2025) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 101.8m | Total funding raised $ 53k |
For sources of this data, please see the company profile
View Company Profiles
GlycoMimetics
HQ
Rockville, US
Employees
50↑ 25% increase
GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers.
View company